TGFB1 and cancer: Emodin treatment in vitro suppressed epithelial-mesenchymal transition and cancer stem cell formation by inactivation of TGF-β1-metiated interactions between tumor-associated macrophages (TAM) and breast cancer cells, and reduced cancer cells migration and metastasis formation [38].